These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8792396)

  • 1. Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.
    Mauras N; Haymond MW
    Pediatr Nephrol; 1996 Jun; 10(3):318-23. PubMed ID: 8792396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
    Mauras N
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N; Doi SQ; Shapiro JR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of human growth hormone and insulin-like growth factor I on whole-body leucine and estimates of protein metabolism.
    Haymond MW; Horber FF; De Feo P; Kahn SE; Mauras N
    Horm Res; 1993; 40(1-3):92-4. PubMed ID: 8300055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
    Mauras N; Horber FF; Haymond MW
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
    Mauras N; Beaufrere B
    J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
    Mauras N; Martinez V; Rini A; Guevara-Aguirre J
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects.
    Hayes VY; Urban RJ; Jiang J; Marcell TJ; Helgeson K; Mauras N
    J Clin Endocrinol Metab; 2001 May; 86(5):2211-9. PubMed ID: 11344229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously.
    Kupfer SR; Underwood LE; Baxter RC; Clemmons DR
    J Clin Invest; 1993 Feb; 91(2):391-6. PubMed ID: 7679407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human growth hormone but not insulin-like growth factor I positively affects whole-body estimates of protein metabolism.
    Haymond MW; Horber FF; Mauras N
    Horm Res; 1992; 38 Suppl 1():73-5. PubMed ID: 1295817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
    Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG
    Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term administration of a combination of recombinant growth hormone and insulin-like growth factor-I induces anabolism in maintenance hemodialysis.
    Guebre-Egziabher F; Juillard L; Boirie Y; Laville M; Beaufrère B; Fouque D
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2299-305. PubMed ID: 19401377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.
    Mauras N; Martha PM; Quarmby V; Haymond MW
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E628-33. PubMed ID: 9142884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human insulin-like growth factor-1 and recombinant human growth hormone on anabolism and immunity in calorie-restricted alcoholic rats.
    Mendenhall CL; Roselle GA; Gartside P; Grossman CJ
    Alcohol Clin Exp Res; 1997 Feb; 21(1):1-10. PubMed ID: 9046366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
    Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I.
    Clark RG; Mortensen DL; Carlsson LM; Carlsson B; Carmignac D; Robinson IC
    Endocrinology; 1996 May; 137(5):1904-12. PubMed ID: 8612530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers.
    Trainer PJ; Holly J; Medbak S; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):801-7. PubMed ID: 7889617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
    Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
    J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.
    Mauras N; O'Brien KO; Welch S; Rini A; Helgeson K; Vieira NE; Yergey AL
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1686-94. PubMed ID: 10770216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.